Intel's stock rallied sharply Monday, fueled by speculation of a landmark chipmaking deal with Apple and a significant share purchase by its CFO, signaling renewed confidence in the company's turnaround strategy.
Adtalem Global Education posts strong Q2 fiscal 2026 results, raising revenue to $503.39M and net income to $76.38M, while reaffirming full-year guidance. The company's new $750M share repurchase authorization signals a dual commitment to capital returns and strategic growth in its healthcare education portfolio, even as regulatory and enrollment challenges linger.
Crane Company's shares have soared over 700% in three years, but recent volatility has investors questioning if the rally is sustainable. A deep dive into valuation metrics reveals a complex picture where traditional models clash.
The data analytics firm's quarterly results soared past estimates, fueled by surging government contracts. CEO Alex Karp touts 'iconic' performance while facing renewed scrutiny over the company's role in immigration enforcement.
Once an open-source developer tool, GitLab has transformed into a unified AI-powered DevSecOps platform. With strong enterprise adoption and a focus on solving the 'AI Paradox,' the company presents a compelling, if competitive, growth story for investors.
As global data center expansion strains power grids, Fluence Energy's energy storage solutions are emerging as a critical piece of infrastructure. Despite recent operational headwinds, a massive backlog and structural demand trends paint a bullish picture for the company.
Insulet Corporation (NASDAQ: PODD), the maker of the tubeless Omnipod insulin delivery system, is drawing investor attention with a potent mix of surging cash flow, market expansion, and a recurring revenue model. As the company capitalizes on recent regulatory wins and international growth, we examine the bull case and the risks ahead.
Despite a cyclical slowdown in manufacturing, industrial distributor Fastenal Company (NASDAQ: FAST) is drawing investor attention for its robust financial health, sticky customer relationships, and a cash-generating model that bulls argue positions it for steady long-term growth.
As semiconductor manufacturing grows more complex, KLA's process control systems are becoming indispensable. With a dominant market position and resilient financials, the company is positioned to capitalize on long-term industry trends, though its premium valuation invites scrutiny.
Once a high-flying SaaS leader, PagerDuty now trades near historic lows despite its critical role in digital operations. As the company navigates a painful pricing model transition, improving fundamentals and persistent takeover speculation present a compelling bull case for patient investors.
Shares of OR Royalties (TSX:OR) have retreated nearly 15% over the past week, prompting investors to reassess the valuation of the precious metals royalty company following its multi-year bull run. With the stock still up significantly year-over-year, we examine whether the dip presents a value entry or reflects justified concerns over its premium pricing.
E.l.f. Beauty reports sustained sales momentum, powered by demand for its affordable products, effectively countering cost pressures from unresolved tariffs. Investor focus sharpens on the company's ability to maintain profitability amid ongoing trade uncertainties.
Quantum computing firm IonQ moves to acquire semiconductor foundry SkyWater Technology and optical communications specialist Skyloom Global, aiming to create the industry's first vertically integrated quantum company and gain tighter control over its core technology stack.
Facing negative pricing at the Waha hub, APA Corporation slashed significant U.S. natural gas and liquids production in late 2025. Simultaneously, the company aggressively repurchased shares, highlighting a capital allocation strategy that prioritizes shareholder returns over volume growth in a volatile market.
BioNTech appoints Kylie Jimenez as its first Chief People Officer, a strategic move aimed at building the organizational and cultural backbone for its ambitious transition into a multi-product oncology company by 2030.
As YouTube TV prepares a direct assault on the sports streaming market, analysts warn that FuboTV's core business model is under unprecedented threat. With subscriber growth stagnating and financial pressures mounting, the company's path to profitability looks increasingly narrow.
Taiwan Semiconductor Manufacturing Company (TSMC) continues to solidify its position as the indispensable engine of the global tech industry. Driven by insatiable AI demand and strategic global expansion, the chipmaking titan's financial performance and long-term outlook are drawing intense investor scrutiny and bullish projections.
After a sharp post-earnings sell-off and insider sales, Power Solutions International (PSIX) faces a critical test. Investors are weighing near-term execution risks against the company's strategic positioning in the surging demand for data center power generation.
Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.
Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.
